Biomni Lab

Biomni Lab is an AI agent platform developed by Phylo, designed for biomedical researchers and biologists. It provides a unified workspace where scientists can collaborate with AI agents to plan, execute, and iterate on research tasks, with the stated goal of reducing the time required for complex analyses from weeks to minutes.

Phylo describes Biomni Lab as an "Integrated Biology Environment" — a workspace that connects natively with the broader ecosystem of biomedical research tools, databases, and software packages, supporting tasks ranging from protein design and multi-omics data analysis to literature review and bioinformatics automation.

Core Capabilities

• Collaborative AI agents that ask clarifying questions, plan tasks alongside the researcher, and iterate based on feedback.
• Execution of complex research tasks in minutes, including protein design, multi-omics data analysis, and summarisation of large volumes of scientific literature.
• Native integration with 68 biomedical databases, 108 software packages, and 82 research tools.
• Scientific rigor checks that scan each step of a task for hallucinations and factual mistakes, with full code output and clear references to maintain transparency and reproducibility.
• Personalisation through continuous background learning of user preferences, while keeping the researcher in full control.
• Scalability to handle multiple concurrent tasks, large files, extended memory, and GPU-level compute.

Security and Compliance

• Phylo holds ISO 27001 certification and is SOC 2 Type 2 compliant.
• Research data is described as protected and private under these compliance frameworks.

Reported Use Cases from Researchers

• Identifying and critically interpreting literature, including data buried in figures, to help refine scientific hypotheses.
• Automating bioinformatics analyses and generating publication-quality figures.
• Comparing experimental results with external datasets.
• Providing a general-purpose biomedical AI agent workflow accessible to scientists without extensive programming experience.

Biomni Lab has received backing from investors including Andreessen Horowitz (A16Z) and Menlo Ventures in a seed round. The platform is positioned for use by individual researchers as well as enterprise teams, with noted adoption at organisations including Ginkgo Bioworks and academic institutions.